Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Med Case Rep
Asıl Yazarlar: Dao, Abou, Benchakroun, Nadia, Jabir, Hamza, Taleb, Amina, Bouchbika, Zineb, Tawfiq, Nezha, Jouhadi, Hassan, Sahraoui, Souha, Benider, Abdellatif
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/
https://ncbi.nlm.nih.gov/pubmed/25488584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller